Linoleic Acid Suppresses Cholesterol Efflux and ATP-binding Cassette Transporters in Murine Bone Marrow-derived Macrophages

Overview

Journal Lipids

Specialty Biochemistry

Date 2014 Mar 6

PMID 24595513

Citations 3

Authors

Nicole L Spartano

Stefania Lamon-Fava

Nirupa R Matthan

Martin S Obin

Andrew S Greenberg

Alice H Lichtenstein

Affiliations

Soon will be listed here.

Abstract

Individuals with type 2 diabetes mellitus (T2DM) are at increased risk of developing cardiovascular disease (CVD), possibly associated with elevated plasma free fatty acid concentrations. Paradoxically, evidence suggests that unsaturated, compared to saturated fatty acids, suppress macrophage cholesterol efflux, favoring cholesterol accumulation in the artery wall. Murine bone marrow-derived macrophages (BMDM) were used to further explore the relationship between saturated and unsaturated fatty acids, and cholesterol efflux mediated by ATP-binding cassette transporters (ABCA1 and ABCG1) through transcription factors liver-x-receptor-alpha (LXR-α) and sterol receptor element binding protein (SREBP)-1. BMDM isolated from C57BL/6 mice were exposed to 100 μM linoleic acid (18:2) or palmitic acid (16:0) for 16 h, and 25 μg/mL oxidized low density lipoprotein for an additional 24 h. ABCA1 and ABCG1 mRNA expression was suppressed to a greater extent by 18:2 (60 % and 54 %, respectively) than 16:0 (30 % and 29 %, respectively) relative to the control (all p < 0.01). 18:2 decreased ABCA1 protein levels by 94 % and high density lipoprotein (HDL) mediated cholesterol efflux by 53 % (both p < 0.05), and had no significant effect on ABCG1, LXR-α or SREBP-1 protein levels. 16:0 had no effect on ABCA1, ABCG1, LXR-α or SREBP-1 protein expression or HDL-mediated cholesterol efflux. These results suggest that 18:2, relative to 16:0, attenuated macrophage HDL-mediated cholesterol efflux through down regulation of ABCA1 mRNA and protein levels but not through changes in LXR-α or SREBP-1 expression. The effect of 18:2 relative to 16:0 on macrophages cholesterol homeostasis may exacerbate the predisposition of individuals with T2DM to increased CVD risk.

Citing Articles

Circulating fatty acids, genetic risk, and incident coronary artery disease: A prospective, longitudinal cohort study.

Zhuang P, Liu X, Li Y, Wu Y, Li H, Wan X Sci Adv. 2023; 9(38):eadf9037.

PMID: 37738352 PMC: 10881029. DOI: 10.1126/sciadv.adf9037.

Atherosclerosis Development and Aortic Contractility in Hypercholesterolemic Rabbits Supplemented with Two Different Flaxseed Varieties.

Bujok J, Mista D, Wincewicz E, Kroliczewska B, Dzimira S, Zuk M Foods. 2021; 10(3).

PMID: 33806676 PMC: 8001360. DOI: 10.3390/foods10030534.

Analysis of Low Molecular Weight Substances and Related Processes Influencing Cellular Cholesterol Efflux.

Litvinov D, Savushkin E, Dergunov A Pharmaceut Med. 2020; 33(6):465-498.

PMID: 31933239 PMC: 7101889. DOI: 10.1007/s40290-019-00308-w.

References

. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25):3143-421. View

Kaplan M, Aviram M, Hayek T . Oxidative stress and macrophage foam cell formation during diabetes mellitus-induced atherogenesis: role of insulin therapy. Pharmacol Ther. 2012; 136(2):175-85. DOI: 10.1016/j.pharmthera.2012.08.002. View

Matthan N, Giovanni A, Schaefer E, Brown B, Lichtenstein A . Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL. J Lipid Res. 2003; 44(4):800-6. DOI: 10.1194/jlr.M200439-JLR200. View

Dillard A, Matthan N, Lichtenstein A . Tamm-Horsfall protein 1 macrophage lipid accumulation unaffected by fatty acid double-bond geometric or positional configuration. Nutr Res. 2011; 31(8):625-30. DOI: 10.1016/j.nutres.2011.08.002. View

Wang X, Rader D . Molecular regulation of macrophage reverse cholesterol transport. Curr Opin Cardiol. 2007; 22(4):368-72. DOI: 10.1097/HCO.0b013e3281ec5113. View

Kohro T, Tanaka T, Murakami T, Wada Y, Aburatani H, Hamakubo T . A comparison of differences in the gene expression profiles of phorbol 12-myristate 13-acetate differentiated THP-1 cells and human monocyte-derived macrophage. J Atheroscler Thromb. 2004; 11(2):88-97. DOI: 10.5551/jat.11.88. View

Brown M, Li W, Nohturfft A, Goldstein J, Espenshade P . Transport-dependent proteolysis of SREBP: relocation of site-1 protease from Golgi to ER obviates the need for SREBP transport to Golgi. Cell. 2000; 99(7):703-12. DOI: 10.1016/s0092-8674(00)81668-2. View

Yoshikawa T, Shimano H, Yahagi N, Ide T, Amemiya-Kudo M, Matsuzaka T . Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J Biol Chem. 2001; 277(3):1705-11. DOI: 10.1074/jbc.M105711200. View

Zhou H, Tan K, Shiu S, Wong Y . Determinants of leukocyte adenosine triphosphate-binding cassette transporter G1 gene expression in type 2 diabetes mellitus. Metabolism. 2008; 57(8):1135-40. DOI: 10.1016/j.metabol.2008.03.020. View

10.

Francke A, Herold J, Weinert S, Strasser R, Braun-Dullaeus R . Generation of mature murine monocytes from heterogeneous bone marrow and description of their properties. J Histochem Cytochem. 2011; 59(9):813-25. PMC: 3201167. DOI: 10.1369/0022155411416007. View

11.

Zeng L, Liao H, Liu Y, Lee T, Zhu M, Wang X . Sterol-responsive element-binding protein (SREBP) 2 down-regulates ATP-binding cassette transporter A1 in vascular endothelial cells: a novel role of SREBP in regulating cholesterol metabolism. J Biol Chem. 2004; 279(47):48801-7. DOI: 10.1074/jbc.M407817200. View

12.

Wang Y, Oram J . Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway. J Biol Chem. 2005; 280(43):35896-903. DOI: 10.1074/jbc.M506210200. View

13.

Mauldin J, Nagelin M, Wojcik A, Srinivasan S, Skaflen M, Ayers C . Reduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitus. Circulation. 2008; 117(21):2785-92. PMC: 2748102. DOI: 10.1161/CIRCULATIONAHA.107.741314. View

14.

Ohashi R, Mu H, Wang X, Yao Q, Chen C . Reverse cholesterol transport and cholesterol efflux in atherosclerosis. QJM. 2005; 98(12):845-56. DOI: 10.1093/qjmed/hci136. View

15.

Mauerer R, Ebert S, Langmann T . High glucose, unsaturated and saturated fatty acids differentially regulate expression of ATP-binding cassette transporters ABCA1 and ABCG1 in human macrophages. Exp Mol Med. 2009; 41(2):126-32. PMC: 2679329. DOI: 10.3858/emm.2009.41.2.015. View

16.

Langmann T, Porsch-Ozcurumez M, Unkelbach U, Klucken J, Schmitz G . Genomic organization and characterization of the promoter of the human ATP-binding cassette transporter-G1 (ABCG1) gene. Biochim Biophys Acta. 2000; 1494(1-2):175-80. DOI: 10.1016/s0167-4781(00)00215-3. View

17.

Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer M . Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007; 28(1):88-136. DOI: 10.1093/eurheartj/ehl260. View

18.

Nohturfft A, Yabe D, Goldstein J, Brown M, Espenshade P . Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes. Cell. 2000; 102(3):315-23. DOI: 10.1016/s0092-8674(00)00037-4. View

19.

Wang Y, Oram J . Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a protein kinase C delta pathway. J Lipid Res. 2007; 48(5):1062-8. DOI: 10.1194/jlr.M600437-JLR200. View

20.

Kakuma T, Lee Y, Higa M, Wang Z, Pan W, Shimomura I . Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. Proc Natl Acad Sci U S A. 2000; 97(15):8536-41. PMC: 26983. DOI: 10.1073/pnas.97.15.8536. View